19.89
0.30%
0.06
After Hours:
19.91
0.02
+0.10%
Entrada Therapeutics Inc Stock (TRDA) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
Revenues |
41.27%
59.12
|
41.85 | 43.73 | 18.17 | 25.26 |
Operating Expenses
|
2.88%
38.01
|
36.94 | 29.72 | 34.47 | 31.04 |
Benefits Costs and Expenses |
100.00%
-
|
-84.31 | - | - | - |
Costs And Expenses |
20.60%
38.01
|
47.87 | 29.72 | 34.47 | 31.04 |
Operating Income/Loss |
330.44%
21.11
|
4.905 | 14.01 | -16.30 | -5.78 |
Income/Loss From Continuing Operations Before Tax |
53.14%
59.12
|
126.15 | 43.73 | -25.93 | -6.674 |
Income Tax Expense/Benefit |
90.23%
1.831
|
18.74 | -17.40 | 13.85 | 3.551 |
Income/Loss From Continuing Operations After Tax |
346.19%
23.50
|
-9.544 | 35.46 | -25.93 | -6.674 |
Net Income/Loss
|
346.19%
23.50
|
-9.544 | 35.46 | -25.93 | -6.674 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
31,100%
33.50
|
0.1074 | 33.28 | 33.16 | 32.37 |
Diluted Average Shares |
2,908%
34.79
|
-1.2391 | 34.78 | 33.16 | 32.37 |
Basic Earnings Per Share |
341.38%
0.70
|
-0.29 | 1.07 | -0.78 | -0.21 |
Diluted Earnings Per Share |
342.86%
0.68
|
-0.28 | 1.02 | -0.78 | -0.21 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):